XML 33 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Financial Instruments
12 Months Ended
Oct. 31, 2020
Investments, All Other Investments [Abstract]  
Financial Instruments Financial Instruments
Cash Equivalents and Available-for-Sale Investments
 As of October 31, 2020As of October 31, 2019
 CostGross
Unrealized
Gain
Gross
Unrealized
Loss
Fair
Value
CostGross
Unrealized
Gain
Gross
Unrealized
Loss
Fair
Value
 In millions
Cash Equivalents:        
Corporate debt$1,700 $— $— $1,700 $1,283 $— $— $1,283 
Financial institution instruments59 — — 59 — — — — 
Government debt2,173 — — 2,173 2,422 — — 2,422 
Total cash equivalents3,932 — — 3,932 3,705 — — 3,705 
Available-for-Sale Investments:
Corporate debt(1)
169 — — 169 — — — — 
Financial institution instruments(1)
32 — — 32 — — — — 
Government debt(1)
73 — — 73 — — — — 
Marketable equity securities and Mutual funds42 16 — 58 40 16 — 56 
Total available-for-sale investments316 16 — 332 40 16 — 56 
Total cash equivalents and available-for-sale investments$4,248 $16 $— $4,264 $3,745 $16 $— $3,761 
(1)HP classifies its marketable debt securities as available-for-sale investments within Other current assets on the Consolidated Balance Sheets, including those with maturity dates beyond one year, based on their highly liquid nature and availability for use in current operations.
All highly liquid investments with original maturities of three months or less at the date of acquisition are considered cash equivalents. As of October 31, 2020 and 2019, the carrying amount of cash equivalents approximated fair value due to the short period of time to maturity. Interest income related to cash, cash equivalents and debt securities was approximately $40 million in fiscal year 2020, $80 million in fiscal year 2019, and $116 million in fiscal year 2018. The estimated fair value of the available-for-sale investments may not be representative of values that will be realized in the future.
Contractual maturities of investments in available-for-sale debt securities were as follows:
 As of October 31, 2020
 Amortized
Cost
Fair Value
 In millions
Due in one year$274 $274 
Non-marketable equity investments in privately held companies are included in Other non-current assets in the Consolidated Balance Sheets. These amounted to $44 million and $46 million as of October 31, 2020 and 2019, respectively.
Derivative Instruments
HP uses derivatives to offset business exposure to foreign currency and interest rate risk on expected future cash flows and on certain existing assets and liabilities. As part of its risk management strategy, HP uses derivative instruments, primarily forward contracts, interest rate swaps, total return swaps, treasury rate locks and, at times, option contracts to hedge certain foreign currency, interest rate and, return on certain investment exposures. HP may designate its derivative contracts as fair value hedges or cash flow hedges and classifies the cash flows with the activities that correspond to the underlying hedged items. Additionally, for derivatives not designated as hedging instruments, HP categorizes those economic hedges as other derivatives. HP recognizes all derivative instruments at fair value in the Consolidated Balance Sheets.
As a result of its use of derivative instruments, HP is exposed to the risk that its counterparties will fail to meet their contractual obligations. Master netting agreements mitigate credit exposure to counterparties by permitting HP to net amounts due from HP to counterparty against amounts due to HP from the same counterparty under certain conditions. To further limit credit risk, HP has collateral security agreements that allow HP’s custodian to hold collateral from, or require HP to post collateral to, counterparties when aggregate derivative fair values exceed contractually established thresholds which are generally based on the credit ratings of HP and its counterparties. If HP’s or the counterparty’s credit rating falls below a specified credit rating, either party has the right to request full collateralization of the derivatives’ net liability position. The fair value of derivatives with credit contingent features in a net liability position was $90 million and $45 million as of October 31, 2020 and 2019, respectively, all of which were fully collateralized within two business days. 
Under HP’s derivative contracts, the counterparty can terminate all outstanding trades following a covered change of control event affecting HP that results in the surviving entity being rated below a specified credit rating. This credit contingent provision did not affect HP’s financial position or cash flows as of October 31, 2020 and 2019.
Fair Value Hedges
HP enters into fair value hedges, such as interest rate swaps, to reduce the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates on HP’s future interest rate payments.
For derivative instruments that are designated and qualify as fair value hedges, HP recognizes the change in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Statements of Earnings in the period of change.
During the fiscal year 2020, HP terminated interest rate swaps with a notional amount of $0.5 billion that were de-designated as fair value hedges of certain fixed rate debt securities that were extinguished. HP also entered into $0.6 billion notional amount interest rate swaps designated as fair value hedges to convert a portion of newly issued $1.15 billion fixed-rate debt to floating.
Cash Flow Hedges
HP uses forward contracts, treasury rate locks, and at times, option contracts designated as cash flow hedges to protect against the foreign currency exchange and interest rate risks inherent in its forecasted net revenue, cost of revenue, operating expenses and debt issuance. HP’s foreign currency cash flow hedges mature predominantly within twelve months; however, hedges related to long-term procurement arrangements extend several years.
For derivative instruments that are designated and qualify as cash flow hedges, HP initially records changes in fair value of the derivative instrument in Accumulated other comprehensive loss as a separate component of stockholders’ deficit in the Consolidated Balance Sheets and subsequently reclassifies these amounts into earnings in the period during which the hedged transaction is recognized in earnings. HP reports the changes in the fair value of the derivative instrument in the same financial statement line item as changes in the fair value of the hedged item.
In March 2020, HP entered into a series of treasury rate lock agreements with notional amounts totaling $750 million to hedge the exposure to variability in future cash flows resulting from changes in interest rate related to an anticipated issuance of long-term debt. These agreements were designated as cash flow hedges and were settled upon issuance of the senior notes in June 2020 resulting in an immaterial loss recognized in Other Comprehensive Income (Loss). The loss will be reclassified to Interest and other, net over the life of the related debt.
Other Derivatives
Other derivatives not designated as hedging instruments consist primarily of forward contracts used to hedge foreign currency-denominated balance sheet exposures. HP uses total return swaps to hedge its executive deferred compensation plan liability.
For derivative instruments not designated as hedging instruments, HP recognizes changes in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Statements of Earnings in the period of change.
Hedge Effectiveness
For interest rate swaps designated as fair value hedges, HP measures hedge effectiveness by offsetting the change in fair value of the hedged item with the change in fair value of the derivative. For foreign currency options and forward contracts designated as cash flow hedges, HP measures hedge effectiveness by comparing the cumulative change in fair value of the hedge contract with the cumulative change in fair value of the hedged item, both of which are based on forward rates.
As of October 31, 2020 and 2019, no portion of the hedging instruments’ gain or loss was excluded from the assessment of effectiveness for fair value and cash flow hedges.
 
Fair Value of Derivative Instruments in the Consolidated Balance Sheets
The gross notional and fair value of derivative instruments in the Consolidated Balance Sheets were as follows:
 As of October 31, 2020As of October 31, 2019
 Outstanding
Gross
Notional
Other
Current
Assets
Other
Non-Current
Assets
Other
Current
Liabilities
Other
Non-Current
Liabilities
Outstanding
Gross
Notional
Other
Current
Assets
Other
Non-Current
Assets
Other
Current
Liabilities
Other
Non-Current
Liabilities
 In millions
Derivatives designated as hedging instruments          
Fair value hedges:          
Interest rate contracts$875 $$— $— $$750 $— $$— $— 
Cash flow hedges:         
Foreign currency contracts15,661 148 30 199 37 15,639 260 111 123 28 
Total derivatives designated as hedging instruments16,536 152 30 199 40 16,389 260 115 123 28 
Derivatives not designated as hedging instruments          
Foreign currency contracts5,319 13 — 20 — 7,146 10 — 14 — 
Other derivatives142 — — — 134 — — 
Total derivatives not designated as hedging instruments5,461 13 — 23 — 7,280 17 — 15 — 
Total derivatives$21,997 $165 $30 $222 $40 $23,669 $277 $115 $138 $28 

Offsetting of Derivative Instruments
HP recognizes all derivative instruments on a gross basis in the Consolidated Balance Sheets. HP does not offset the fair value of its derivative instruments against the fair value of cash collateral posted under its collateral security agreements. As of October 31, 2020 and 2019, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:
 In the Consolidated Balance Sheets  
 (i)(ii)(iii) = (i)–(ii)(iv)(v) (vi) = (iii)–(iv)–(v)
 Gross Amount
Recognized
Gross Amount
Offset
Net Amount
Presented
Gross Amounts
Not Offset
  
 DerivativesFinancial
Collateral
 Net Amount
 In millions
As of October 31, 2020       
Derivative assets$195 $— $195 $156 $(1)$35 
Derivative liabilities$262 $— $262 $156 $130 (2)$(24)
As of October 31, 2019       
Derivative assets$392 $— $392 $113 $259 (1)$20 
Derivative liabilities$166 $— $166 $113 $43 (2)$10 
(1)Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
(2)Represents the collateral posted by HP through re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
 
Effect of Derivative Instruments in the Consolidated Statements of Earnings
The pre-tax effect of derivative instruments and related hedged items in a fair value hedging relationship was as follows:
Derivative InstrumentHedged ItemLocationFor the fiscal years ended October 31Total amounts of income/ (expense) line items in the statement of financial performance in which the effects of fair value hedges are recordedGain/ (loss) recognized in earnings on derivative instrument(Loss)/ gain recognized in earnings on hedged item
    In millions
Interest rate contractsFixed-rate debtInterest and other, net2020$(231)$$(6)
2019(1,354)27 (27)
2018(818)(11)11 

The pre-tax effect of derivative instruments in cash flow hedging relationships included in Accumulated other comprehensive loss was as follows:
For the fiscal years ended October 31
 202020192018
 In millions
(Loss)/ gain recognized in Accumulated other comprehensive loss on derivatives:
Foreign currency contracts$(197)$252 $341 
Interest rate contracts$(4)$— $— 

The pre-tax effect of derivative instruments in cash flow hedging relationships included in earnings were as follows:
Total amounts of income/ (expense) line items in the statement of financial performance in which the effects of cash flow hedges are recordedGain/ (loss) reclassified from Accumulated other comprehensive loss into earnings
For the fiscal years ended October 31For the fiscal years ended October 31
202020192018202020192018
In millionsIn millions
Net revenue$56,639 $58,756 $58,472 $108 $425 $(239)
Cost of revenue(46,202)(47,586)(47,803)(25)(43)(18)
Operating expenses(6,975)(7,293)(6,838)(2)(1)
Total$3,462 $3,877 $3,831 $85 $380 $(258)
As of October 31, 2020, HP expects to reclassify an estimated Accumulated other comprehensive loss of approximately $57 million, net of taxes, to earnings within the next twelve months associated with cash flow hedges along with the earnings effects of the related forecasted transactions. The amounts ultimately reclassified into earnings could be different from the amounts previously included in Accumulated other comprehensive loss based on the change of market rate, and therefore could have different impact on earnings.
The pre-tax effect of derivative instruments not designated as hedging instruments recognized in Interest and other, net in the Consolidated Statements of Earnings for fiscal years 2020, 2019 and 2018 was as follows:
 Gain/ (loss) recognized in earnings on derivative instrument
 Location202020192018
  In millions
Foreign currency contractsInterest and other, net$40 $(119)$35 
Other derivativesInterest and other, net(9)14 (9)
Total $31 $(105)$26